openPR Logo
Press release

New investments expected to boost the Histoplasmosis Treatment Market between 2017 and 2025

01-29-2018 07:28 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Persistence Market Research

/ PR Agency: Persistence Market Research
New investments expected to boost the Histoplasmosis Treatment

Histoplasmosis is an infection that occurs from breathing spores of a fungus called Histoplasma capsulatum. Histoplasmosis is a fungal infection that occurs throughout the world. Histoplasma fungus grows as a mold in the soil. The soil that contains the droppings of bat or birds usually contains large amount of this fungus. The people with weakened immune system are usually more prone and increases the risk of being affected or reactivated with histoplasmosis. Usually people very young, old people and people affected with cancer, AIDS or organ transplant have severe symptoms. The people with chronic lung disease such as bronchiectasis or emphysema have high risk of severe pain. The common symptoms of histoplasmosis is fever, chills, cough, chest pain, red skin bumps, mouth sores etc. In some patients suffering from histoplasmosis may spread throughout the body and cause irritation and swelling in response to infection.

Request Report for TOC @ https://www.persistencemarketresearch.com/toc/18115

Certain symptoms also includes chest pain from swelling in lining of heart, neck stiffness etc. The disease is usually diagnosed with biopsy of lungs, skin, liver or bone marrow. Certain blood and urine test also help in detection histoplasmosis proteins or antibodies of the fungus in body. In some cases doctors also perform Chest CT scan, Chest X-ray, Bronchoscopy etc.

The histoplasmosis treatment is segmented based on drugs used such as Amphotericin B, Itraconazole, ketoconazole and others. The main treatment for the disease includes antifungal drugs. Most of the time the disease is cured without any treatments but in some cases where the symptoms are visible for more than 1 month the doctor prescribes anti-fungal drugs. Sometimes the drugs is also administered through IV route depending upon the form or the stage of disease. In certain cases the patients are also administered with treatment for long term with antifungal drug approximately 2 to 3 years.

The global market for histoplasmosis treatment market is expected to be driven by the increasing number of aging population, increasing prevalence of AIDS or organ failure. The key drivers of the market are the increasing prevalence of cancer cases. The increasing concerns with aging health problems is expected to drive the market within the forecast period of 2017-2027. However, the cost and critical reimbursement scenarios is expected to act as challenge to the growth of this market.

The increasing investment by the government and public organizations to provide better healthcare quality is expected to drive the market. Based on the product histoplasmosis treatment are based on drugs used such as amphotericin B, itraconazole, Ketoconazole and others.

By distribution channel, the global histoplasmosis treatment has been segmented into hospitals pharmacies, private clinics, drug stores and retail pharmacy and E-commerce.

By regional presence, histoplasmosis treatment is segmented into five key regions viz. North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. North America will continue to dominate the histoplasmosis treatment market due to high occurrence of this disease in this area and better availability of healthcare facilities, better disposable income. Europe is expected to hold second largest market share in global histoplasmosis treatment. The increasing focus towards better healthcare system and the increasing geriatric populations, cancer cases and AIDS cases in APAC region is expected to grow the histoplasmosis treatment market in this region.

Request to Sample of Report @ https://www.persistencemarketresearch.com/samples/18115

Some of the major players in global histoplasmosis treatment includes Bristol Myers Squibb, Sigma tau pharmaceuticals Inc., Three rivers pharmaceuticals llc, Astellas pharma US Inc., Abbott laboratories, Abraxis pharmaceutical products, Teva parenteral medicines Inc., X gen pharmaceuticals Inc. and others.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New investments expected to boost the Histoplasmosis Treatment Market between 2017 and 2025 here

News-ID: 919118 • Views:

More Releases from Persistence Market Research

Ultrasonic Level Sensors Market Size to Reach New Heights by 2032, Driven by Rising Automation in Industrial Processes | Trending Report by Persistence Market Research
Ultrasonic Level Sensors Market Size to Reach New Heights by 2032, Driven by Ris …
Introduction The Ultrasonic Level Sensors Market has gained significant traction in recent years due to their increasing adoption in various industries, including oil & gas, water and wastewater treatment, pharmaceuticals, and food & beverage. These sensors utilize ultrasonic waves to measure the level of fluids and solids in tanks, reservoirs, and silos, providing accurate and reliable data for process automation and control. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐏𝐃𝐅- https://www.persistencemarketresearch.com/samples/20824 (Use Corporate Mail Id for
Phenol Market to Reach $41.4B by 2032 with 4.9% CAGR | Persistence Market Research
Phenol Market to Reach $41.4B by 2032 with 4.9% CAGR | Persistence Market Resear …
The global phenol market is expected to grow from US$ 28.1 billion in 2024 to US$ 41.4 billion by 2032, registering a CAGR of 4.9%. The market's growth is driven by the increasing use of phenol in pharmaceuticals, chemical manufacturing, and consumer products such as mouthwash, disinfectants, and detergents. Additionally, rapid urbanization and construction activities have boosted demand for phenolic resins used in plywood and flooring panels. Phenol also finds
Ammonia Market to Reach $193.7B by 2032 with 4.7% CAGR | Persistence Market Research
Ammonia Market to Reach $193.7B by 2032 with 4.7% CAGR | Persistence Market Rese …
The global ammonia market is projected to reach US$ 122.4 Bn in 2022, growing at a CAGR of 4.7% from 2022 to 2032, with sales expected to hit US$ 193.7 Bn by 2032. The South Asia and Pacific region will remain a key market due to high consumption in India and ASEAN countries. Ammonia demand is driven by the agriculture sector, especially for fertilizers, and industrial applications like explosives manufacturing.
Silica Gel Market to Reach $889M by 2033 with 3.6% CAGR | Persistence Market Research
Silica Gel Market to Reach $889M by 2033 with 3.6% CAGR | Persistence Market Res …
The global silica gel market is projected to grow at a CAGR of 3.6% from 2023 to 2033, reaching US$ 889.0 million by 2033. Growth is driven by rising demand in pharmaceuticals, food packaging, and chromatography applications. The paints and coatings industry is also fueling market expansion due to silica gel's moisture-absorbing properties. However, stringent environmental regulations on blue silica gel containing cobalt chloride and the availability of cheaper alternatives

All 5 Releases


More Releases for Histoplasmosis

Histoplasmosis Treatment Market future outlook with Rising Trends 2022-2028
Histoplasmosis Treatment Market report is the ultimate tool to help industries, businesses, and organizations make informed decisions for business growth. With the help of the market tactics and strategies covered here, it becomes easy for business players to maintain their position in the market. Market study plays an important role to gain an improved outlook as well as an understanding of the market scenario and goal market. It also allows
Histoplasmosis Treatment Market to Register Incremental Dollar Opportunity Durin …
Histoplasmosis is an infection that occurs from breathing spores of a fungus called Histoplasma capsulatum. Histoplasmosis is a fungal infection that occurs throughout the world. Histoplasma fungus grows as a mold in the soil. The soil that contains the droppings of bat or birds usually contains large amount of this fungus. The people with weakened immune system are usually more prone and increases the risk of being affected or reactivated with
Histoplasmosis Treatment Market 2019 Analysis and Precise Outlook - Bristol Myer …
The report titled “Histoplasmosis Treatment Market” report will be very useful to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, SWOT analysis, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners and industry experts. The Histoplasmosis Treatment market was
Global Histoplasmosis Treatment Market Research Report 2020, Segment by Key Comp …
According to HJ Research's study, the global Histoplasmosis Treatment market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2026, expanding at a CAGR of XX% during the forecast period. The report on Histoplasmosis Treatment market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc. In this
Histoplasmosis Treatment Market to Witness a Pronounce Growth During 2017 - 2025
Histoplasmosis is an infection that occurs from breathing spores of a fungus called Histoplasma capsulatum.Histoplasmosis is a fungal infection that occurs throughout the world. Histoplasma fungus grows as a mold in the soil. The soil that contains the droppings of bat or birds usually contains large amount of this fungus. The people with weakened immune system are usually more prone and increases the risk of being affected or reactivated with
Pipeline Assessment on Histoplasmosis Global Clinical Trials with Analysis of On …
Market Research Hub's clinical trial report, “Histoplasmosis Global Clinical Trials Review, H2, 2017" provides an overview of Histoplasmosis clinical trials scenario. This report provides top line data relating to the clinical trials on Histoplasmosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end